$22.46
▼ $-1.98
(-8.10%)
Vol 138K
Wall Street Consensus
9 analysts · Apr 20265
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
PCRX
Pacira Biosciences Inc
P/E 51.9
$1.1B
PHAT
Phathom Pharmaceuticals Inc
$1.2B
BIOA
BIOAGE Labs Inc
$474.4M
OMER
Omeros Corp
$1.2B
RLMD
Relmada Therapeutics Inc
$354.2M
ARVN
Arvinas Inc
$761.7M
ETON
Eton Pharmaceuticals Inc
$453.5M
LXRX
Lexicon Pharmaceuticals Inc
$417.9M
ESPR
Esperion Therapeutics Inc
$884.5M
Quarterly Revenue & Earnings
| Quarter | 2024-1… |
|---|---|
| Revenue | — |
| Net Income | -$8.4M |
Financial Health
Free Cash Flow
-$6.7M
Net Debt
-$102.4M
Cash
$106.0M
Total Debt
$3.6M
As of Sep 30, 2025
Peer Comparison
| Ticker | Mkt Cap | P/E | P/S | ROE | Margin | Beta |
|---|---|---|---|---|---|---|
| SGP | — | — | — | — | — | — |
| PCRX | $1.1B | 51.9 | 1.6 | 2.8% | 3.0% | 0.25 |
| PHAT | $1.2B | — | 8.0 | -232.8% | -186.5% | 0.48 |
| BIOA | $474.4M | — | — | -25.1% | — | 1.59 |
| OMER | $1.2B | — | 17.1 | 107.5% | -202.0% | 2.58 |
| RLMD | $354.2M | — | — | -269.5% | — | 0.78 |
| ARVN | $761.7M | — | 2.4 | -9.8% | -18.7% | 1.87 |
| ETON | $453.5M | — | 6.4 | -27.9% | -9.5% | 1.22 |
Latest News
No related news yet